Orphazyme A/S revised earnings guidance for the year 2021. For the year, the company expects net revenues to be in the range of DKK 35 million to DKK 37 million compared to previous guidance range of DKK 30 million to DKK 40 million. Operating loss to be in the range of DKK 630 million to DKK 640 million compared to previous guidance range of DKK 670 million to DKK 700 million.